LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...

As a result of the planned project work, a complete
package of generic specification profiles can be made
available for networkable documentation platforms. In
addition, the necessary conceptual, legal and technical
preconditions are created to place the recruitment of
extensive samples for clinical studies and epidemiological
and economic studies on a broader basis. In addition,
within the framework of a business model, economic
framework conditions can be defined, in order to place any
future adaption and implementation by other competence
networks on a basis that would ensure success. Finally,
practical experience values will be assured through the
exemplary implementation of a case implementation of the
neuropsychiatric research networks.
Research project for the cross-sectoral analysis of
healthcare of people with mental disorders: “Crossdisciplinary
and –sectoral healthcare analysis with the
aim of optimising the healthcare situation of people with
mental and psychosomatic illnesses”
Project director: W. Gaebel
Scientific assistants: J. Zielasek, S. Kowitz
Financing: Federal Medical Chamber
Cooperation partner: Federal Medical Chamber; DGPPN,
IGES Institute of Health System Research, Berlin; VdEK,
Berlin; HKK, DAK, KKH.
In this third-party–funded project, obtained from the
DGPPN in 2008 and funded within the healthcare research
programme of the Federal Medical Chamber, for the first
time data from three health insurance companies will be
combined anonymously with the datasets from the German
Pension Insurance Association in order to carry out a
cross-sectoral analysis of the utilisation of health services
because of mental disorders. Indicators for over-, underand
inadequate healthcare will be identified and analysed.
In addition to descriptive statistical procedures, methods
will also be used to model healthcare systems. The aim is to
obtain information regarding the necessary improvements
in mental healthcare by analysing treatment pathways and
identifying predictors of unfavourable disease courses such
as somatic comorbidity.
Additional Mental Health Survey within the
German Health Survey 2009-2011
Project director: W. Gaebel
Scientific assistant: J. Zielasek
Financing: DGPPN, Federal Health Ministry
Cooperation partner: DGPPN; Institute for Psychology, TU
Dresden (U. Wittchen), Robert Koch Institute Berlin (B. Kurth)
In this project, funded by the DGPPN, the project group has
carried out – within the context of the new additional Mental
108
of the German Health Survey (Project director: Robert Koch
Institute, Berlin) – investigations since 2008 into the early
diagnosis of psychotic disorders in the general population by
means of questionnaire interviews with around 7,000 German
citizens. The investigations are designed to determine the
frequency of subclinical psychotic symptoms in the general
population in a cross-sectional study and then follow up these
individuals in future surveys, thereby providing new knowledge
about the prospective significance of subclinical psychotic
phenomena in healthy adults, which could be significant for
the early diagnosis and prevention of psychoses.
3.1.3.8 Transcranial magnet stimulation
Director: J. Cordes
Scientific assistants: E. Ben Sliman, K. Hoppe,
S. Arnau, T. Nolting, J. Brinkmeyer, S. J. Kim, J. Kotrotsios,
L. Kostorz, M. Arends, F. Hellen
Clinical assistants: J. Closset, C. Lange-Asschenfeldt,
B. Stueken, T. Salamon, J. Malevani, C. von Hirsch,
J. Kotrotsios, C. Huck
Doctoral candidates: S. J. Kim, J. Kotrotsios
Internal cooperation: W. Wölwer, W. Gaebel,
A. Mobascher, P. Kienbaum, T. Klenzner, C. Plettenberg
External cooperation: Ruhr University, Bochum:
M. W. Agelink, J. Kornischka; Georg-August University,
Göttingen: P. Falkai, T. Wobrock; University of Regensburg:
B. Langguth, G. Hajak, P. Eichhammer, M. Landgrebe;
Offenbach City Hospital: A. Klimke
Financing: German Research Association (GRA)
16
14
12
10
8
6
4
2
0
GAF Score Health Survey (Coordinator: U. Wittchen, Dresden) as part
Control group rTMS
Figure 23: Statistically significant (p=0.048) improvement of global
functioning (measured as improvement in the Global Assessment of
Functioning (GAF) scale) in patients with schizophrenia with pronounced
negative symptoms (score on the negative symptom scale of the Positive
and Negative Symptom Scale (PANSS) > 17) after treatment with repetitive
transcranial magnetic stimulation (rTMS) compared to a control group
(figure modified after: Cordes et al., Psychiatr. Res. 2009; DOI:10.1016/j.
psychres.2009.01.014)